Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDiploma Regulatory News (DPLM)

Share Price Information for Diploma (DPLM)

Share Price is delayed by 15 minutes
Get Live Data
7,130.00    80.00 (1.13%)
Bid:
7,110.00
Ask:
7,120.00
Spread: 10.00 (0.141%)
Market Cap: £9.56b
DPLM Live PriceLast checked at - London Stock Exchange

Intraday Diploma Share Chart

Trading Statement

20 Jan 2021 07:00

RNS Number : 2115M
Diploma PLC
20 January 2021
 

 

DIPLOMA PLC

12 CHARTERHOUSE SQUARE, LONDON EC1M 6AX

TELEPHONE: +44 (0)20 7549 5700

FACSIMILE: +44 (0)20 7549 5715

 

FOR IMMEDIATE RELEASE

 

20 January 2021

 

 

DIPLOMA PLC

 

 

FIRST QUARTER TRADING UPDATE

 

STRONG TRADING AND THREE HIGH QUALITY BOLT-ON ACQUISITIONS IN Q1

 

Diploma PLC, the international group supplying specialised products and services, is today issuing its first quarter trading update in respect of the year ending 30 September 2021, ahead of the Company's closed door AGM today at 12.00, midday.

 

 

Group

 

Diploma has made a strong start to the year with improved trends in underlying trading across all of the Group's three Sectors in the first quarter. The Group delivered underlying revenues in line with last year's pre-Covid comparative, reflecting strong execution of our organic growth initiatives. Reported Group revenues in the first quarter ended 31 December 2020 increased by 24% over the comparable period, driven by an excellent first quarter contribution from Windy City Wire (WCW) which is trading very well following a smooth transition into the Group.

 

The following table sets out the year-on-year revenue performance by Sector for Q1 alongside a reminder of the exit rates reported for September 2020:

 

Sector performance

Q1

Sept 20

Life Sciences

Underlying

+8%

+2%

 

Reported

+10%

 

 

 

 

 

Seals

Underlying

-2%

-4%

 

Reported

-0%

 

 

 

 

 

Controls

Underlying

-1%

-18%

 

Reported

+71%

 

 

 

 

 

Group

Underlying

+0%

-7%

 

Reported

+24%

 

 

 

Life Sciences

 

Life Sciences delivered strong underlying growth of 8%, driven by an encouraging performance in consumables in both clinical diagnostics and specialty surgical equipment in Australia and Canada, as well as higher than normal levels of capital installations due to pent up demand from last year's lockdowns. In Q2, we expect growth rates to moderate with lockdowns in Canada impacting capital sales and surgical procedures. However, the Sector remains well positioned to capitalise on the backlog of surgical procedures and lab testing as the year progresses.

 

 

Seals

 

Seals traded well with underlying revenues improving to -2%. The Group continues to see strong performances from International Seals due to the diversity of end markets and North American Aftermarket due to continued strong repair shop demand. The North American OEM business has been recovering well in the last two quarters, and we are confident in its prospects under a strengthened management team. The transition to the new Aftermarket automated facility in Louisville has completed successfully and will support future market share gains.

 

 

Controls

 

Underlying revenues have seen a strong recovery since the start of year, improving to -1% reflecting the execution of initiatives to diversify the Sector's revenue streams. Reported revenues were up 71% due to the contribution from WCW. After a smooth transition into the Group WCW is trading very well, growing both revenues and profits broadly in line with their impressive track record and ahead of our initial expectations. Some benefits from Brexit inventory build in Q1 are likely to unwind in the coming weeks and, along with the impact of further UK lockdowns, may impact Q2 trading in Controls. However, the Sector's healthier revenue profile will underpin a return to growth this year.

 

 

Acquisitions

 

Bolt-on acquisitions remain a core part of the Group's strategy. The first quarter has been active with £48.8m invested in three high quality, strategically important bolt-on acquisitions to build scale in core markets and enhance our organic growth ambitions:

 

· Simonsen & Weel (annualised revenues ca.£25m), an excellent Healthcare business based in Denmark and building the Life Sciences Sector's presence in Northern Europe;

· FITT Resources (annualised revenues ca.£13m), a well established, high quality Seals business that significantly strengthens the Sector's footprint in Eastern Australia; and

· Power Dynamics (annualised revenues ca.£5m), a gasket bolt-on for VSP within our NA Seals business, expanding VSP's presence across the Northern US.

 

 

Financial position

 

As previously stated, the Group's equity raise in September 2020 allowed Diploma to retain balance sheet flexibility following the acquisition of WCW. This has enabled the Group to pursue its bolt-on acquisition strategy while maintaining a strong financial position. After three bolt-on acquisitions in Q1, net debt at year-end is expected to be at around 1.2x EBITDA.

 

 

Outlook

 

Inevitably uncertainties remain with respect to the duration and impact of the Covid-19 pandemic. However, while the pandemic may modestly affect Q2 revenues, we are pleased with the Group's trading performance. Excluding the contribution from the acquisitions completed in the quarter, full year expectations for the underlying business remain positive and unchanged. 

 

 

Enquiries:

 

Diploma PLC -

Johnny Thomson, Chief Executive Officer

+44 (0)20 7549 5700

Barbara Gibbes, Chief Financial Officer

 

 

 

 

 

Tulchan Communications -

+44 (0)20 7353 4200

Martin Robinson

 

Olivia Peters

 

 

 

 

 

 

Notes:

 

1. This trading update is based upon unaudited management accounts and has been prepared solely to provide additional information on trading to the shareholders of Diploma PLC. It should not be relied on by any other party for other purposes. Certain statements made in this update are forward-looking statements. Such statements have been made by the Directors in good faith using information available up until the date that they approved this Statement. Forward-looking statements should be regarded with caution because of the inherent uncertainties in economic trends and business risks.

 

2. Diploma PLC uses alternative performance measures as key financial indicators to assess the underlying performance of the Group. All references in this Statement to "underlying" revenues refer to reported results on a constant currency basis and before any contribution from acquired or disposed businesses.

 

3. A copy of this Statement, together with further information about Diploma PLC, may be viewed on its website at www.diplomaplc.com

 

 

 

 

 

LEI: 2138008OGI7VYG8FGR19

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTGPUGUGUPGGAB
Date   Source Headline
1st Jun 20264:00 pmRNSAppointment of Non-Executive Director
21st May 20265:01 pmRNSDirector/PDMR Shareholding
19th May 20267:00 amRNSHalf Year Results
20th Apr 20265:33 pmRNSHolding(s) in Company
9th Apr 20261:16 pmRNSHolding(s) in Company
23rd Mar 20263:02 pmRNSDirector/PDMR Shareholding
18th Mar 20267:00 amRNSSignificant upgrade to FY26 guidance
27th Feb 20261:45 pmRNSAppointment of Non-Executive Director
27th Jan 20264:06 pmRNSHolding(s) in Company
16th Jan 20263:05 pmRNSDirector/PDMR Shareholding
15th Jan 202610:30 amRNSDirector/PDMR Shareholding
14th Jan 20263:53 pmRNSResult of AGM
14th Jan 20267:00 amRNSQ1 2026 Trading Update
22nd Dec 20257:00 amRNSDirector/PDMR Shareholding
22nd Dec 20257:00 amRNSDirector/PDMR Shareholding
19th Dec 20251:33 pmRNSHolding(s) in Company
19th Dec 20251:33 pmRNSHolding(s) in Company
18th Dec 202510:52 amRNSHolding(s) in Company
17th Dec 20257:00 amRNSChief Financial Officer appointment
8th Dec 20257:00 amRNSAnnual Financial Report & Notice of AGM
1st Dec 20257:00 amRNSTotal Voting Rights
26th Nov 20257:00 amRNSDirector/PDMR Grant of LTIP Awards
19th Nov 20252:17 pmRNSDirector/PDMR Shareholding
19th Nov 20257:00 amRNSDirector/PDMR Shareholding
18th Nov 20257:00 amRNSPreliminary Results
13th Nov 20257:00 amRNSIssue of Shares & Total Voting Rights
7th Oct 20257:00 amRNSDirector Declaration
2nd Oct 20252:41 pmRNSHolding(s) in Company
14th Aug 20257:00 amRNSChief Financial Officer update
17th Jul 20257:00 amRNSQ3 Trading Update
2nd Jul 20259:49 amRNSHolding(s) in Company
20th Jun 20259:50 amRNSHolding(s) in Company
9th Jun 202512:50 pmRNSHolding(s) in Company
28th May 20259:27 amRNSHolding(s) in Company
21st May 20254:07 pmRNSDirector/PDMR Shareholding
20th May 20257:00 amRNSHalf-year Report
19th May 202511:02 amRNSHolding(s) in Company
19th May 202510:57 amRNSHolding(s) in Company
9th May 20254:24 pmRNSHolding(s) in Company
6th May 20259:32 amRNSHolding(s) in Company
11th Apr 20253:44 pmRNSHolding(s) in Company
3rd Apr 20257:03 amRNSDirector Declaration
25th Mar 20257:00 amRNSDirector/PDMR Shareholding
24th Mar 20259:36 amRNSHolding(s) in Company
24th Mar 20257:00 amRNSDirector/PDMR Shareholding
24th Mar 20257:00 amRNSDirector/PDMR Shareholding
18th Mar 20259:54 amRNSHolding(s) in Company
3rd Mar 202510:15 amRNSDirector Declaration - External Appointment
25th Feb 20257:00 amRNSHolding(s) in Company
14th Feb 20253:20 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.